|
|
| |
 |
Avian Influenza (Bird Flu): Agricultural and Wildlife Considerations
CIDRAP-authored overview, updated Jan 13 with new research
|
|
|
Avian Influenza (Bird Flu): Implications for Human Disease
CIDRAP-authored overview, updated Jan 7 with new research
|
|
|
Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza
|
|
|
Predicting the anticipated emotional and behavioral responses to an avian flu outbreak
From Am J Infect Control, published online Jan 5
|
|
|
Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N
From PLoS Pathog, published online Jan 2
|
|
|
Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge
|
|
|
Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children
From PLoS ONE, published online Dec 29
|
|
|
Personal protective equipment and risk for avian influenza (H7N3)
From Emerg Infect Dis, published online Dec 23
|
|
|
Experimental infection of dogs with avian-origin canine influenza A virus (H3N2)
From Emerg Infect Dis, published online Dec 23
|
|
|
Avian influenza virus (H5N1) in human, Laos
Letter from Emerg Infect Dis, published online Dec 23
|
|
|
Indigenous sources of 2007-2008 H5N1 influenza outbreaks in Thailand
|
|
|
Risk factors and characteristics of H5N1 highly pathogenic avian influenza (HPAI) post-vaccination outbreaks
From Vet Res, published online Dec 12
|
|
|
First case of highly pathogenic H5N1 avian influenza virus in Spain
From BMC Vet Res. published online Dec 10
|
|
|
Influenza vaccine based on baculovirus surface display system of Bombyx mori
From PLoS ONE, published online Dec 12
|
|
|
Antibody persistence after 2-dose priming and booster response to a third dose of an inactivated, adjuvanted, whole-virion H5N1 vaccine
From J Infect Dis, published online Dec 9
|
|
|
Genetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine
|
|
|
Evaluation of live attenuated influenza A virus H6 vaccines in mice and ferrets
|
|
|
Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques
From J Infect Dis, published online Dec 5
|
|
|
Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam, 2004-2005
From Emerg Infect Dis, published online Dec 3
|
|
|
Effects of influenza A virus infection on migrating mallard ducks
From Proc R Soc B, published online Dec 2
|
|
|
FSIS seeks comments on draft risk assessment for the public health impact of highly pathogenic avian influenza virus in poultry, shell eggs, and egg products
Dec 2 USDA press release (see report below)
|
|
|
Draft interagency risk assessment for the public health impact of highly pathogenic avian influenza virus (HPAIV) in poultry, shell eggs, and egg products
USDA report described in above release
|
|
|
Knowledge about avian influenza, European region
Letter from Emerg Infect Dis, published online Nov 25
|
|
|
Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes
From J Infect Dis, published online Nov 25
|
|
|
Cross-reactive immunity in adult and elderly patients against clade 2 influenza A H5N1 virus strains induced by Fluval, a reverse genetic-derived adjuvanted H5N1 clade 1 prototype pandemic influenza vaccine
From Clin Vaccine Immunol, published online Nov 19
|
|
|
Characterization of H9N2 influenza viruses isolated from vaccinated flocks in an integrated broiler chicken operation in eastern China during a 5-year period (1998-2002)
|
|
|
Map of Confirmed Cases of H5N1 Avian Flu
From pandemicflu.gov; updated frequently
|
|
